Based on our demonstration of VprBP being overexpressed and stimulating melanoma cell growth, an important question is whether VprBP knockdown or inhibition exhibits anti-melanomagenic efficacy through blocking VprBP kinase activity toward H2AT120 and thus decreasing VprBP transrepression potential. Here, DCAF1 is linked to melanoma.